Medline ® Abstract for Reference 101
of 'Cutaneous side effects of conventional chemotherapy agents'
Distinctive acral erythema occurring during therapy for severe myelogenous leukemia.
Levine LE, Medenica MM, Lorincz AL, Soltani K, Raab B, Ma A
Arch Dermatol. 1985;121(1):102.
A distinctive acral erythema developed in four patients with myelogenous leukemia, subsequent to blood transfusions and intensive chemotherapy with cytarabine. The clinical and histopathologic features of the eruption were suggestive of a drug-induced toxic eruption. To our knowledge, only one previous similar case has been reported in the literature. For patients in whom this self-limited condition develops, reassurance should serve as the mainstay of therapy.